View Press Releases
-
Aalto Bio Reagents is pleased to announce the availability of the first highly reactive recombinant Rubella Spike Ectodomain (E1-E2) antigen
-
Kyruus Announces Significant Core Business Momentum in 2020 as it Accelerates Expansion into the Health Plan Market with Recent Acquisition
-
IDBS and Scitara announce a strategic partnership to integrate the Scitara Digital Lab Exchange (DLX™) platform with Polar™, IDBS’ Biopharmaceutical Lifecycle Management (BPLM) platform
-
THREAD and 1nHealth Partner to Optimize Participant Recruitment in Decentralized Clinical Trials
Strategic alliance will streamline patient-centric recruitment for sponsors and CROs, ultimately improving recruitment and retention outcomes in decentralized clinical trials
Feb 1, 2021
-
Dotmatics collaborates with HighRes Biosolutions to provide single software interface for lab digitalization
Integration of Dotmatics’ ELN with HighRes Biosolutions’ Cellario instrument control software will streamline experiments and workflows Scientists will be able to plan experiments and run instruments from the ELN
Feb 1, 2021
-
BioIVT Unveils COVID-19 Panel to Accelerate Vaccine-generated Immune Response Research
The panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples.
Feb 14, 2021
-
Antibiotic Research UK calls for clear guidance to ensure people on antibiotics do not miss out on the COVID-19 vaccine
Antibiotic Research UK (ANTRUK), the UK’s only charity focused on tackling bacterial antibiotic resistance, is urging the UK Government to publish clear national guidelines about whether people on antibiotics should have the COVID-19 vaccination.
Feb 11, 2021
-
MMS HOLDINGS JOINS DECENTRALIZED TRIALS & RESEARCH ALLIANCE (DTRA) AS A FOUNDING MEMBER TO ACCELERATE THE ADOPTION OF PATIENT-FOCUSED CLINICAL TRIALS
MMS Holdings – an award-winning, data-focused CRO – joins a historic alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The “Decentralized Trials & Research Alliance (DTRA),” which launched on December 10th, 2020, plans to unite industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices, and new technologies in decentralized clinical research.
Jan 28, 2021
-
Baltimore Aircoil Company Announces HXV Hybrid Cooler
-
Solentim wins New Product Award at SLAS 2021
Solentim wins a New Product Award from the Society for Laboratory Automation and Screening (SLAS), annouced this week at SLAS Digital 2021. Solentim achieved this award with the launch of its new ICON™ and STUDIUS™ technologies.
Jan 28, 2021
-
ComputaBio Introduces Molecular Dynamics Analysis Services to Drug Development Scientists
ComputaBio, a US supplier of professional computational biology services, has introduced its molecular dynamics analysis services for industrial and academic scientists to expedite their drug development projects.
Jan 27, 2021
-
Lifeasible Developed Thermal Analysis Platform for Material Research
-
Matexcel Introduced Mechanical Environment Reliability Test Worldwide
-
Alfa Chemistry Launches MOF Chemicals for the Science Community
As the fastest growing class of materials in chemistry today, metal-organic frameworks (MOFs) have become ideal candidates for storage of fuels (hydrogen and methane), capture of carbon dioxide, and catalysis applications as well as many other applications. To meet the increasing market demand accompanying this trend, Alfa Chemistry has recently launched a subsidiary website, which is specially designed for supplying MOF chemicals, COFs linkers, and MOF materials.
Jan 19, 2021
-
Prime Global and Raremark form strategic partnership to transform solutions and outcomes for patients with rare diseases
Medical communications company, Prime Global, and healthcare technology company, Raremark®, announced today that they have formed a strategic partnership to transform solutions for patients with rare diseases. Together, the companies will uncover insights into the entire patient journey that will allow the creation of truly patient-centric drug development and commercialisation programs. Focusing on the needs of patients is the key to powerful communications that make a tangible difference to patient outcomes.
Jan 20, 2021
-
CluePoints’ Risk-Based Quality Management Platform Instrumental in Data Quality Oversight of COVID-19 Trials
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that its Risk-Based Quality Management (RBQM) platform has been critical in supporting numerous Pharmaceutical companies and CROs to interrogate data in their global COVID-19 vaccine and antiviral antibody trials to ensure data quality and integrity.
Jan 20, 2021
-
Domainex expands executive team to support ongoing growth
Domainex welcomes David Cronk to the team as its new Chief of Staff and promotes long standing team member and previous Head of Chemistry, Dr Ray Boffey, to Executive Director of Medicines Research.
Jan 20, 2021
-
PhenoTips® launches Pre-Visit Patient Questionnaires that automatically generate pedigrees using patient-entered data
PhenoTips, creator of the world’s first complete Genomic Health Record™, has launched a digital tool that automatically generates pedigrees from patient-entered information. Pre-Visit Patient Questionnaires are delivered virtually to patients, building pedigrees and patient records in advance of a patient’s initial consultation, which improves the appointment efficiency by over 50% due to the elimination of manual data entry.
Jan 20, 2021
-
Bally Ribbon Mills Manufacturing Materials to Ensure Health and Safety of Front-Line Workers
The press release announces Bally Ribbon Mills continues to focus on producing its line of narrow woven structural tapes and elastics, as well as safety webbing, to protect front-line workers responding to the current global health crisis.
Jan 20, 2021
-
Alfa Chemistry Recently Launched a Sub-website for Functional Polymers
Alfa Chemistry announced the launch of a new sub-website for the supply of functional polymers, including Adsorptive Polymers, Biomedical Polymers, Electrofunctional Polymers, Functional PEGs, Photoactive Polymers, Silicone Polymers and more.
Jan 20, 2021